NDC 0781-6014

Brinzolamide

Brinzolamide

Brinzolamide is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Brinzolamide.

Product ID0781-6014_9fc22b67-1ddb-4b7f-bbf8-f8ddf1d9554a
NDC0781-6014
Product TypeHuman Prescription Drug
Proprietary NameBrinzolamide
Generic NameBrinzolamide
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2021-03-08
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA020816
Labeler NameSandoz Inc
Substance NameBRINZOLAMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0781-6014-70

1 BOTTLE, PLASTIC in 1 CARTON (0781-6014-70) > 10 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2021-03-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Brinzolamide" or generic name "Brinzolamide"

NDCBrand NameGeneric Name
0591-2127BrinzolamideBrinzolamide
0781-6014BrinzolamideBrinzolamide
24208-464BRINZOLAMIDEbrinzolamide
63629-8793BrinzolamideBrinzolamide
68682-464BRINZOLAMIDEbrinzolamide
0065-0275Azoptbrinzolamide
0078-0722Azoptbrinzolamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.